Gene Silencing/Gene Editing News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics. May 29, 2019 CRISPR Framework Helps Identify Combination Therapies for Optimal Targeting of KRAS Mutant Apr 10, 2019 Genome-Scale CRISPR Screening Helps Identify New Cancer Drug Targets Sep 28, 2018 BRCA1 Methylation Level May Predict Which Ovarian Cancer Patients Respond to PARP Inhibitors Sep 12, 2018 Saturation Editing of BRCA1 Exons Reveals Functional, Non-Functional Variants Breaking News KSQ Therapeutics Begins Combination Dosing in Trial of USP1 Inhibitor for Advanced Solid Tumors Daiichi Sankyo Transfers Rights to Market Yescarta in Japan to Gilead Sciences Enhertu Shows Activity in Early-Stage HER2-Low Breast Cancer Patients in Study Reported at SABCS Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy
